The assessment of factor affecting toxicity of multikinase inhibitor pazopanib in soft tissue sarcoma

Trial Profile

The assessment of factor affecting toxicity of multikinase inhibitor pazopanib in soft tissue sarcoma

Recruiting
Phase of Trial: Phase II

Latest Information Update: 05 Feb 2015

At a glance

  • Drugs Pazopanib (Primary)
  • Indications Soft tissue sarcoma
  • Focus Pharmacokinetics
  • Most Recent Events

    • 05 Feb 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top